Internal Medicine, Rheumatology · Atlanta, GA
NPI
1174536478
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
6
Hospital affiliations
371 E Paces Ferry Rd NE Ste 525
Atlanta, GA, 30305
Phone (404) 355-1799
Medicare paid, 2024
$3.1M
129,101 services
Medicare patients, 2024
435
Average age 72
Drug cost, 2024
$1.8M
2,561 prescriptions
Company payments, 2025
$4,519
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rattandeep Singh was code J3262 (injection, tocilizumab, 1 mg), 47,480 times for 12 patients. In total Rattandeep Singh billed 129,101 services in 56 codes, and Medicare paid $3.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 47,480 | 12 | $4.70 | $223K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,600 | 14 | $9.13 | $97K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,930 | 30 | $24.80 | $221K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,600 | 14 | $33.21 | $219K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,801 | 46 | $0.10 | $290 |
| J0897 Injection, denosumab, 1 mg | Office | 2,580 | 28 | $20.61 | $53K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,573 | 17 | $0.23 | $358 |
| 99214 Office E&M - Established | Office | 740 | 347 | $97.37 | $72K |
| 96413 Chemotherapy Administration | Office | 642 | 86 | $108.27 | $70K |
| 96415 Chemotherapy Administration | Office | 316 | 47 | $23.40 | $7,396 |
| 96375 Injection Administration | Office | 307 | 43 | $12.83 | $3,939 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 225 | 38 | $0.64 | $145 |
| 96401 Chemotherapy Administration | Office | 173 | 41 | $60.56 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 99 | $13.54 | $1,693 |
| 73120 X-ray - Upper Extremity | Office | 116 | 60 | $25.45 | $2,952 |
By year: 2022 $2.1M for 81,483 services; 2023 $1.9M for 107,441 services; 2024 $3.1M for 129,101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rattandeep Singh prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 269 prescriptions and refills. In total Rattandeep Singh wrote 2,561 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 269 | 654 | 92 | $11K |
| Prednisone Generic | 232 | 388 | 100 | $2,034 |
| Methotrexate Methotrexate Sodium | 154 | 355 | 60 | $2,394 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 134 | 136 | 27 | $3,064 |
| Tramadol Hcl Generic | 126 | 126 | 39 | $771 |
| Celecoxib Generic | 106 | 180 | 27 | $3,708 |
| Duloxetine Hcl Generic | 96 | 203 | 31 | $2,067 |
| Gabapentin Generic | 85 | 130 | 28 | $1,167 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 75 | 80 | 14 | $1,242 |
| Meloxicam Generic | 75 | 125 | 32 | $391 |
| Allopurinol Generic | 56 | 143 | 25 | $419 |
| Diclofenac Sodium Generic | 44 | 70 | 19 | $963 |
| Leflunomide Generic | 44 | 98 | 14 | $2,954 |
| Pantoprazole Sodium Generic | 42 | 90 | 14 | $476 |
| Alprazolam Generic | 42 | 42 | Under 11 | $150 |
Brand drugs: - claims; generic drugs: 2,277 claims; opioid claims: 403.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rattandeep Singh $4,519 ($4,519 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $856.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.